For efficient transfection of cell lines, e.g. A549, Caco-2, CHO-K1, HT-, or U-87 MG, in the NucleofectorTM NucleofectorTM I/II/2b Device
Cryopreserved ampule of Human Peripheral Blood CD8+ T Cells containing 10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood CD4+ T Cells containing ≥10 million cells, negatively selected.
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Naïve Kupffer cells derived from human liver tissue. 0.2 million cells per vial
Naïve Kupffer cells derived from human liver tissue. 0.5 million cells per vial.
For efficient transfection of primary human T cells in the Nucleofector® I/II/2b System
-
TheraPEAK® T-VIVO® Cell Culture Medium – OverviewView or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
-
Terms and Conditions TheraPEAK T-VIVO Sample Request Program
-
Instructions for Use - TheraPEAK® T-VIVO® Cell Culture MediumInstructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell ExpansionThis poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
TechSheet - X-VIVO™ Media SystemsInstructions for how to use the X-VIVO™ Media Series
-
Non-viral Gene Modification for Ex-vivo Cell TherapyIn this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
-
Two Distinct Activation Methods Yield Clinical-Scale Expansion of Peripheral Blood Derived γδ T CellsIn this study, we demonstrate that billions of γδ T cells can be generated from peripheral blood mononuclear cells (PBMCs) with two distinct activation methods, using TheraPEAK® T-VIVO® Medium.
-
4D-Nucleofector® LV Unit for Large-scale TransfectionEfficient, closed and scalable transfection for ex vivo cell and gene therapy applications